Walking the antibody catwalk
Therapeutic antibody design and engineering – is this modality still relevant – is C> taking over, or is there a resurgence of small molecules?
FACILITATED BY
ALAN BOYD | CEO & Founder | Boyds
PANELLISTS
MARC WILKINSON | Partner, European and UK Patent Attorney | J A Kemp LLP
JOLYON MARTIN | Co-Founder and Head of Business Development | PetMedix